We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+11%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$6.83B
AUM Growth
+$439M
Cap. Flow
-$277M
Cap. Flow %
-4.05%
Top 10 Hldgs %
26.62%
Holding
140
New
27
Increased
39
Reduced
39
Closed
23

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$127M
2
ANAB icon
AnaptysBio
ANAB
+$76M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$62.1M
4
TSM icon
TSMC
TSM
+$59.5M
5
LKQ icon
LKQ Corp
LKQ
+$45.9M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$89.2M
2
CNC icon
Centene
CNC
+$80.2M
3
HOLX
Hologic
HOLX
+$75.2M
4
ECYT
Endocyte, Inc. Common Stock
ECYT
+$65.8M
5
BAX icon
Baxter International
BAX
+$63.9M

Sector Composition

Rank Sector Weight
1 Healthcare 49.61%
2 Technology 13.09%
3 Communication Services 5.22%
4 Consumer Discretionary 2.37%
5 Financials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTRS icon
126
CALL
Viatris
VTRS
$20.4B
-1,271,700
Closed -$46M
Z icon
127
Zillow
Z
$7.79B
-366,797
Closed -$21.7M
CUTR
128
DELISTED
Cutera, Inc.
CUTR
-487,347
Closed -$19.6M
LCI
129
CALL
DELISTED
Lannett Company, Inc.
LCI
-399,500
Closed -$21.7M
TWTR
130
DELISTED
Twitter, Inc.
TWTR
-1,172,793
Closed -$51.2M
MNK
131
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
-1,259,100
Closed -$23.5M
NITE
132
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
-1,016,980
Closed -$16.3M

Similar funds

PFM Health Sciences's Q3 2018 Portfolio in Review

As of Q3 2018, PFM Health Sciences held 140 positions worth $6.83B, up 6.9% from $6.39B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

PFM Health Sciences withdrew a net $277M in Q3 2018, closing 23 positions and reducing 39 holdings. Its most notable exit was Baidu, an estimated $89.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 49% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Allergan plc worth $131M.

  • PFM Health Sciences's largest Q3 2018 buy was Allergan plc: 689,949 shares worth $131M.
  • PFM Health Sciences added most to AnaptysBio in Q3 2018, an estimated $76M increase.
  • PFM Health Sciences's biggest Q3 2018 reduction was Endocyte, Inc. Common Stock, cutting an estimated $65.8M.
  • PFM Health Sciences fully exited Baidu in Q3 2018, selling an estimated $89.2M.
  • PFM Health Sciences's ten largest holdings make up 27% of its $6.83B portfolio in Q3 2018.
  • PFM Health Sciences opened 27 new positions and closed 23 in Q3 2018.
  • PFM Health Sciences's portfolio value rose 6.9% quarter-over-quarter to $6.83B.

Based on PFM Health Sciences's 13F filing for Q3 2018, filed 13 Nov 2018.